BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cellzome AG to Study Epigenetic Factors with Neusentis


5/10/2011 11:06:06 AM

Heidelberg, Germany – 10 May 2011 – Cellzome announced today a joint project with Pfizer’s Pain & Sensory Disorders and Regenerative Medicine unit ‘Neusentis’, to characterize epigenetic factors involved in stem cell differentiation using Cellzome’s EpisphereTM technology.

The aim of the project is to shed light on the epigenetic mechanisms involved in the regulation of stem cell differentiation. Pfizer will provide its know-how in stem cell handling and regenerative medicine, while Cellzome will apply its world-leading chemoproteomics platform to chart the changes of epigenetic factors during stem cell differentiation.

Tim Edwards, CEO of Cellzome said: “This is a very exciting collaboration in an emerging area of science. Cellzome can monitor epigenetic factors in their natural complexes directly throughout stem cell differentiation. We look forward to working with Pfizer to gain fundamental insights into epigenetic regulation which may be instrumental for any therapeutic applications in regenerative medicine.”

For more information please contact:

Cellzome:

Tim Edwards

Chief Executive Officer

Tel: +49 (0) 6221-137 57-100

press@cellzome.com

Media contact:

Nicole Yost, Jayne Crook

College Hill

Tel: +44 (0)20 7866 7862

cellzome@collegehill.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->